Carregant...
Receptor Tyrosine Kinases Fall into Distinct Classes Based on Their Inferred Signaling Networks
Although many anticancer drugs that target receptor tyrosine kinases (RTKs) provide clinical benefit, their long-term use is limited by resistance that is often attributed to increased abundance or activation of another RTK that compensates for the inhibited receptor. To uncover common and unique fe...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3987808/ https://ncbi.nlm.nih.gov/pubmed/23861540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.2003994 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|